Company Description
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia.
The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services.
Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables.
The company also provides installation and verification, technical training, and support services.
Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications.
The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007.
Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
Country | United States |
IPO Date | Jul 15, 2021 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 193 |
CEO | Robert G. Spignesi Jr. |
Contact Details
Address: 1001 Pawtucket Boulevard West Lowell, Massachusetts United States | |
Website | https://www.rapidmicrobio.com |
Stock Details
Ticker Symbol | RPID |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001380106 |
CUSIP Number | 75340L104 |
ISIN Number | US75340L1044 |
Employer ID | 00-0000000 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Robert G. Spignesi Jr. | Chief Executive Officer, President & Director |
John J. Addington Wilson | Chief Operating Officer |
Sean M. Wirtjes CPA | Chief Financial Officer |
James Xu | Vice President of Legal & Secretary |
Kristine Williams | Senior Vice President of Product |
Michael Beaulieu C.F.A. | Vice President of Investor Relations & Corporate Communications |
Michael Wysocki | Senior Vice President of Sales & Marketing |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 05, 2024 | 4 | Filing |
Nov 27, 2024 | 4 | Filing |
Nov 12, 2024 | 8-K | Current Report |
Nov 07, 2024 | 10-Q | Quarterly Report |
Nov 01, 2024 | 8-K | Current Report |
Aug 09, 2024 | 4 | Filing |
Aug 08, 2024 | 4 | Filing |
Aug 07, 2024 | 4 | Filing |
Aug 07, 2024 | 4 | Filing |
Aug 02, 2024 | 10-Q | Quarterly Report |